Abstract
Ethnic classification does not correlate well with skin tone. As there are no neonatal skin color scales, we aimed to create and validate one of our own. After creating the scale and briefly training our staff, we conducted a prospective, observational study to assess reproducibility and correlation of each scale color with the melanin and erythema indexes and transcutaneous bilirubin. The reliability of our color scale was measured using Kappa agreement (and its 95% confidence interval) and the concordance index by comparing inter-observer classification of neonatal skin color. We also calculated inter-rater agreement with the intraclass correlation coefficient (ICC). The Kendall tau-b correlation coefficient was used to test the correlation between our color scale and the Mexameter® MX 18. We obtained data from 258 newborns. Inter-observer agreement on color assignment was 83.2%. Median melanin index was significantly different among the 4 color groups, whereas erythema index and transcutaneous bilirubin were not.
Conclusions: Our proposed neonatal skin color scale correlates well with the melanin index at 24 h of life, increasing from colors 1 to 4, and the only chromophore different among our four color groups is melanin. Scale color assignment is reproducible. Therefore, it can be used to classify neonatal skin color. Further research is warranted to assess the clinical relevance of these findings.
What is known: • Classifying neonates by skin color is difficult because to date there are no skin color scales available based on real skin tone regardless of ethnicity or country of origin. • Skin color differs among individuals from a given ethnic group and depends, among others, on melanin and hemoglobin. | |
What is new: • We created a neonatal skin color scale based on real skin color. • We conducted a study to validate it, and confirmed a good inter-observer agreement in color assignment as well as a good correlation between each color in the scale and the median melanin level. |
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Neonatal jaundice is common, affecting 60–85% of term infants. Even though it is usually mild and does not need treatment, it must be controlled in order to avoid potential negative consequences [1, 2]. Pathological jaundice is the most common cause of readmission to the neonatal unit [3, 4]. The current tendency to early discharge newborns after birth raises concern about a potential underdiagnosis of pathological jaundice after discharge. Preventive interventions for the early detection of neonatal hyperbilirubinemia include the determination of transcutaneous total bilirubin [2,3,4,5]. Jaundice meters have been widely used and validated for monitoring bilirubin levels in the newborn for many years. The first generation of bilirubinometers showed an accuracy strongly limited by skin pigmentation; however, their reliability has improved over the past few years [6]. Their use is painless for the newborn and cheaper than measuring serum bilirubin [7, 8]. However, some controversies remain as to its reliability depending on gestational age, ethnic group or skin color, and exposure to phototherapy [9,10,11,12,13,14,15,16].
We treat a multiethnic population at our hospital; therefore, newborns have varying skin tones. Neonates have been classified depending on ethnicity, related skin tones, or following cosmetic charts in the literature. However, a neonatal skin color scale based on real skin tone regardless of ethnicity or country of origin does not exist to date [11,12,13,14,15,16,17]. In some cases, different skin colors have been demonstrated to interfere with transcutaneous bilirubin measurements; therefore, we believed that a skin color classification of neonates would help physicians to reassure the reliability of the transcutaneous bilirubin measurements [13, 14]. We created our own scale of four skin tones based on the real skin colors of newborns in the first 24 h of life, regardless of their parents’ origin and conducted this study in order to validate our own neonatal color scale that we decided to call "Neomar neonatal skin color scale".
Our objectives were to assess agreement in skin color assignment determined by our specific neonatal skin color scale between different observers, and to compare the skin color assignment with the values of melanin obtained by the colorimeter Mexameter® MX 18.
Patients and methods
This was a prospective, observational study that aimed to validate a specific neonatal skin color scale which we developed (Fig. 1). We compared inter-observer color assignment according to our neonatal skin color scale with the objective measure of skin melanin with a spectrophotometer.
All our newborns were eligible to participate if their parents agreed to and signed a written informed consent (Appendix). We expected that the number of patients in each skin tone group would be balanced except for the “Dark” group which would perhaps account for less than a quarter of the newborns given the ethnic characteristics of our population.
We created a skin color scale of 4 groups based upon the newborn’s chest skin and nipples/areolae compared with photographs of neonatal chests (two patients per color) taken at 24 h of life. These eight photographs were taken in our neonatal unit in the morning, with ambient light, in the same place, with the same camera in automatic mode, without flash and at the same distance (15 cm) and angle (90°). We chose two patients of each color to create our color scale, but we did not take photos of the enrolled patients. We used a Canon PowerShot S95 digital camera (Canon Inc., Tokyo, Japan) ISO 3200 with a resolution of 10.0 megapixels.
After a brief training on the use of the new color scale, all doctors, nurses, and nurse assistants who work in our neonatal unit participated in this study by collecting cases and registering data. Patient recruitment started in October 2016 and finished when we enrolled the targeted number of patients (258 cases). Two observers, who were blinded to each other’s decision and to melanin index, assigned every newborn to a color group at 24 h of life according to our skin color scale. Color assignment was done in our neonatal unit, which is artificially illuminated; therefore, the environmental light conditions were the same regardless of the time of day. Our neonatal unit ambient light intensity is 100–120 lux.
At the moment of color assignment, skin melanin and erythema indices were measured in the sternal region with a non-invasive technique using the skin colorimeter Mexameter® MX 18 (Courage + Khazaka electronic GmbH, Köln, Germany). This reflectance meter is based on absorption/reflection of the light from the skin. Its probe emits three specific light wavelengths: 568, 660, and 870 nm, which correspond to green, red, and infrared light, respectively. A receiver measures the light reflected by the skin. As the quantity of emitted light is defined, the quantity of light absorbed by the skin can be calculated. The Mexameter® MX 18 provides the measurement of absorbed and reflected light at green and red wavelengths for hemoglobin and wavelengths in the red and the near-infrared for melanin. A melanin index is computed from the intensity of the absorbed and the reflected light at 660 and 880 nm, respectively. An erythema index is computed from the intensity of the absorbed and the reflected light at 568 and 660 nm. It is only necessary to apply the probe on the skin for 1 s. Measurements are not affected by other pigments such as bilirubin. The results are expressed as melanin and erythema indices in arbitrary units on a scale from 0 to 999. Measurement uncertainty is ± 5% [18, 19]. All measurements with the Mexameter® MX 18 were performed in the same room (our neonatal unit) with no daylight and under controlled ambient conditions (26 ± 2 °C).
Transcutaneous bilirubin was measured in the sternal region in all the participants at moment of color assignment (24 h after birth) by means of a jaundice meter (Dräger Jaundice Meter JM-105, Minolta, Dräger 157 Medical GmbH, Lübeck, Germany).
All newborns were in a quiet state, not receiving phototherapy, with intact skin and good peripheral perfusion at the moment of color assignment and of melanin, erythema, and transcutaneous bilirubin measurements.
Statistical analyses
We calculated that we needed a minimum sample size of n = 249 in order to obtain a Kappa index ≥ 0.7 taking into account a precision of 0.1 (which is the 95% confidence interval) and a p1 of 0.2 and p2 of 0.3 (which are the proportions that the observers 1 and 2 would give positive in a certain color category). We used Stata (STATA 12.0, College Station, Texas, USA) to calculate sample size and to perform the statistical analyses.
To analyze inter-observer agreement in the classification of neonatal skin color with our scale, we measured the Kappa index agreement and its 95% confidence interval. We also calculated inter-rater agreement with the intraclass correlation coefficient (ICC).
The Kendall tau-b correlation coefficient was used to test the correlation between our color scale and the Mexameter® MX 18 and between our color scale and the erythema index and transcutaneous bilirubin. We also compared the melanin index, erythema index, and transcutaneous bilirubin in the different skin color groups with ANOVA and Sidak post hoc tests. We also modeled the variable “skin color” as a function of the melanin and erythema indices and the transcutaneous bilirubin. Taking into account that our outcome is an ordered outcome in terms of color scale, we performed an ordered logistic regression taking color = 1 as the base.
Our hospital Ethics Committee accepted and approved this study. We obtained a written informed consent from the participants’ parents prior to enrolling them in the study. After creating our own neonatal skin color scale (see details in Fig. 1), we classified newborns according to this scale.
Results
We enrolled 258 healthy newborns in the present study: 112 from color 1, 98 from color 2, 40 from color 3, and 8 from color 4. Most were full-term infants who were not under phototherapy at the time of color assignment and melanin/erythema index measurement. Table 1 describes characteristics of our population and color groups. There were no differences among the four color groups in terms of gender, gestational age, birth weight, birth length, type of delivery, prematurity rate, or feeding choice. There were significant differences in the melanin index between the four groups (Kruskal Wallis, p = 0.000). There were no differences in the erythema index among the groups (Kruskal Wallis, p = 0.431). There were no differences in the levels of transcutaneous bilirubin among color groups 1, 2, and 3. There were differences between colors 1, 2, and 3 compared with color 4 (Kruskal Wallis, p = 0.029).
During the study, failures in the Mexameter® MX 18 did not allow us to obtain data for long periods, so the recruitment took longer than planned, a total of 2 years. The Kappa value was 0.73 (CI 95% 0.66–0.81, p < 0.001) for inter-observer agreement for color assignment according to our skin color scale. Thus, the agreement was substantial, as they agreed on 83% of the neonates. The ICC was 0.878 (CI 95% 0.847–0.904, p < 0.000).
Levels of mean melanin were significantly different (p < 0.001) among the 4 color groups (Fig. 2). Mean melanin index was 107 for color 1, 139 for color 2, 171 for color 3, and 278 for color 4. The Kendall tau-b correlation between our color scale and the Mexameter® MX 18 was 0.447 (p < 0.000). This indicates a moderate association between x (color scale) and y (Mexameter® MX 18).
The Kendall tau-b correlation between our color scale and erythema was 0.053 (p NS) and between our color scale and transcutaneous bilirubin, 0.099 (p 0.043). Thus, those parameters show no relevant correlation. Erythema index and transcutaneous bilirubin did not show significant differences between the different skin color groups (Fig. 2 and Tables 2 and 3), whereas melanin index was significantly different (Fig. 2 and Tables 2 and 3). Moreover, in the ordered logistic regression, the color group classification was only significantly associated with melanin. Taking color = 1 as the base, the odds ratio (OR) for melanin was 1.02 (CI 95% 1.01–1.03, p < 0.001).
Discussion
The accuracy and early diagnosis of pathological jaundice in a hospital with early discharge policies and a multiethnic population with varying skin tones, such as ours, is of great importance due to the risks of underdiagnosis [1,2,3,4,5]. Therefore, the reliability of the transcutaneous determination of bilirubin, although improved in the recent years [6], must be analyzed in these multiethnic populations because there are still some controversies on the impact of skin color [11,12,13,14,15,16]. In order to do so, we should be able to classify newborns depending on skin color.
Classifying neonates into ethnic groups is complicated, imprecise, and unreliable, due to the variability of skin color within the same ethnic group and an overlapping of skin types. Few studies have been done to measure the skin color of neonates, and there are not many studies which evaluate the impact of skin color on the accuracy of bilirubinometers in multiethnic populations [11,12,13,14,15,16,17, 20]. Currently available color scales are based on adult skin, which has been exposed to the sun, like the Fitzpatrick skin type chart. A reliable classification of skin phototype or skin color or tone does not exist for the newborn. The only two studies which classified newborns by skin color used color references from registered facial cosmetic brands to define three subgroups (light, medium, and dark) [15, 16]. One study evaluated the effect of skin pigmentation on the accuracy of pulse oximetry in infants with hypoxemia classified skin color using the Munsell System Soil Color Chart (2009 Revision, Munsell Color, Grand Rapids, Michigan), Hue 7.5YR [17]. However, all these colors differ greatly from the real neonatal skin tones; therefore, we decided to create and validate our own scale of four skin tones based on the real skin colors of newborns in the first 24 h of life. We believed that by classifying newborns according to their skin color, we would increase the reliability of transcutaneous bilirubin determination in each color group, and therefore avoid unnecessary blood tests as well as underdiagnosed pathological jaundice.
In order to validate our scale, we had to assess inter-observer reproducibility and agreement and also consider that actual skin color is affected by many substances. The main determinant of skin color is the pigment melanin, followed by hemoglobin. This is why we focused our study on their measurement, by means of the melanin index and the erythema index. The device we used, the Mexameter® MX 18, determines both pigments. The Mexameter® MX 18 is one of the two most used devices in dermatological research [19] and has been used in prior studies to assess skin color. Matias et al. compared skin color analyses by the Mexameter® MX 18, Antera® 3D, and Skin-Colorimeter® CL 400 in a sample of 30 adults who were exposed to a controlled ultraviolet B light [19]. Md Isa et al. measured skin color in first trimester pregnant women in Malaysia and compared the reliability of the Fitzpatrick skin type chart to the Mexameter® MX 18 [21]. Park used the same device to measure skin color of neonatal infants [20].
A limitation of our study is that we did not focus on other minor skin chromophores such as reduced hemoglobin, collagen, carotenes, and vitamins (e.g., riboflavin) [8, 22, 23]. However, melanin and hemoglobin are the main factors that determine skin color in healthy newborn infants who have not been exposed to food, chemicals, medication, or a stimulant such as sun light [20]. We considered that reduced hemoglobin would be irrelevant in our study because all the participants were healthy babies and had a normal oxygenation. We found differences in transcutaneous bilirubin between color type 4 and the others, but we believe that this is due to the small sample size of color 4 neonates and we would rather not draw conclusions from this. We did not measure serum bilirubin at 24 h of life when assessing skin color. However, we did measure serum bilirubin at 48–72 h with preliminary results indicating a good correlation with transcutaneous bilirubin. These results are anticipated to be published soon.
In the assessment of reproducibility and inter-rater reliability, we measured inter-observer agreement both with the intraclass correlation coefficient (ICC) and with the Kappa statistic. We obtained a good ICC 0.878 (CI 95% 0.847–0.904, p < 0.000) [24]. The result of the Kappa index of 0.73 is considered to be “substantial” according to Cohen, and is accepted as a good agreement for healthcare research because it is over 0.60. However, a better agreement with, for example, a Kappa above 0.81 would be better since it would be considered to be “almost perfect” [25].
We believe that our study confirms both of our hypotheses: our scale allows the classification of neonates according to skin color with a good inter-observer reproducibility and it correlates well with the melanin index (light skin has a lower melanin index than dark skin). More studies will be required to further validate the scale in other hospitals and to assess its clinical usefulness. We are currently conducting an observational study to assess correlation of transcutaneous and serum bilirubin depending upon skin color to reaffirm the clinical usefulness of our neonatal skin color scale.
Conclusions
Our proposed skin color scale correlates well with the level of melanin in neonatal skin at 24 h of life for colors 1, 2, and 3. A larger sample of color 4 neonates would allow us to obtain more reliable results for this group. Our results show that the only chromophore different among our four color groups is melanin, as there are no differences between the erythema index and the levels of transcutaneous bilirubin. This new neonatal skin color scale is reproducible and can be readily used to classify neonatal skin color. We are currently completing additional research that aims to establish the clinical relevance of the use of our neonatal skin color scale in order to increase the accuracy of the transcutaneous bilirubin determination.
References
Bertini G, Rubaltelli FF (2002) Non-invasive bilirubinometry in neonatal jaundice. Semin Neonatol 7(2):129–133
Muchowski KE (2014) Evaluation and treatment of neonatal hyperbilirubinemia. Am Fam Physician 89(11):873–878
Battersby C, Michaelides S, Upton M, Rennie JM, Jaundice Working Group of the Atain (Avoiding Term Admissions Into Neonatal units) programme, led by the Patient Safety team in NHS Improvement (2017) Term admissions to neonatal units in England: a role for transitional care? A retrospective cohort study. BMJ Open 7(5):e016050. https://doi.org/10.1136/bmjopen-2017-016050
De Luca D, Carnielli VP, Paolillo P (2009) Neonatal hyperbilirubinemia and early discharge from the maternity ward. Eur J Pediatr 168(9):1025–1030. https://doi.org/10.1007/s00431-009-0969-1
Maisels MJ (2015) Transcutaneous bilirubin measurement: does it work in the real world? Pediatrics 135(2):364–366. https://doi.org/10.1542/peds.2014-3472
Capasso L, Parrella C, Borrelli AC, Maffucci R, Milite P, Sodano A et al (2012) Is it worthwhile using a transcutaneous bilirubinometer in the nursery? Early Hum Dev 88(Suppl 2):S25–S26. https://doi.org/10.1016/S0378-3782(12)70008-7
Mazur MG, Mihalko-Mueller J, Callans H, Klesh D, Sell H, Bendig D (2014) Reproducability of non-invasive bilirubin measurements. MCN Am J Matern Child Nurs 39(4):225–230. https://doi.org/10.1097/NMC.0000000000000048
Engle WD, Jackson GL, Engle NG (2014) Transcutaneous bilirubinometry. Semin Perinatol 38(7):438–451. https://doi.org/10.1053/j.semperi.2014.08.007
Grabenhenrich J, Grabenhenrich L, Bührer C, Berns M (2014) Transcutaneous bilirubin after phototherapy in term and preterm infants. Pediatrics. 134(5):e1324–e1329. https://doi.org/10.1542/peds.2014-1677
Zecca E, Barone G, De Luca D, Marra R, Tiberi E, Romagnoli C (2009) Skin bilirubin measurement during phototherapy in preterm and term newborn infants. Early Hum Dev 85(8):537–540. https://doi.org/10.1016/j.earlhumdev.2009.05.010
Raimondi F, Lama S, Landolfo F, Sellitto M, Borrelli AC, Maffucci R, Milite P, Capasso L (2012) Measuring transcutaneous bilirubin: a comparative analysis of three devices on a multiracial population. BMC Pediatr 12:70. https://doi.org/10.1186/1471-2431-12-70
Afanetti M, Eleni Dit Trolli S, Yousef N, Jrad I, Mokhtari M (2014) Transcutaneous bilirubinometry is not influenced by term or skin color in neonates. Early Hum Dev 90(8):417–420. https://doi.org/10.1016/j.earlhumdev.2014.05.009
Maisels MJ, Ostrea EM Jr, Touch S, Clune SE, Cepeda E et al (2004) Evaluation of a new transcutaneous bilirubinometer. Pediatrics. 113(6):1628–1635
Taylor JA, Burgos AE, Flaherman V, Chung EK, Simpson EA, Goyal NK, Von Kohorn I, Dhepyasuwan N (2015) Better outcomes through research for newborns network. Discrepancies between transcutaneous and serum bilirubin measurements. Pediatrics 135(2):224–231. https://doi.org/10.1542/peds.2014-1919
Samiee-Zafarghandy S, Feberova J, Williams K, Yasseen AS, Perkins SL, Lemyre B (2014) Influence of skin colour on diagnostic accuracy of the jaundice meter JM 103 in newborns. Arch Dis Child Fetal Neonatal Ed 99(6):F480–F484. https://doi.org/10.1136/archdischild-2013-305699
Wainer S, Rabi Y, Parmar SM, Allegro D, Lyon M (2009) Impact of skin tone on the performance of a transcutaneous jaundice meter. Acta Paediatr 98(12):1909–1915. https://doi.org/10.1111/j.1651-2227.2009.01497.x
Foglia EE, Whyte RK, Chaudhary A, Mott A, Chen J, Propert KJ et al (2017) The effect of skin pigmentation on the accuracy of pulse oximetry in infants with hypoxemia. J Pediatr 182:375–377.e2. https://doi.org/10.1016/j.jpeds.2016.11.043
Brochure Mexameter® MX 18- Assessing melanin content and erythema level. Seen on July 26, 2019. Available from: https://www.courage-khazaka.de/images/Downloads/Brochures/Wissenschaftlich/Brochure_Mexameter.pdf
Matias AR, Ferreira M, Costa P, Neto P (2015) Skin colour, skin redness and melanin biometric measurements: comparison study between Antera(®) 3D, Mexameter(®) and Colorimeter(®). Skin Res Technol 21(3):346–362. https://doi.org/10.1111/srt.12199
Park JH, Lee MH (2005) A study of skin color by melanin index according to site, gestational age, birth weight and season of birth in Korean neonates. J Korean Med Sci 20(1):105–108. https://doi.org/10.3346/jkms.2005.20.1.105
Md Isa Z, Shamsuddin K, Bukhari NBI, Lin KG, Abdullah Mahdy Z, Hassan H, Ghazi HF (2016) The reliability of Fitzpatrick skin type chart comparing to Mexameter (Mx 18) in measuring skin color among first trimester pregnant mothers in Petaling District, Malaysia. Malaysian Journal of Public Health Medicine 3:59–65
Mahmoud BH, Hexsel CL, Hamzavi IH, Lim HW (2008) Effects of visible light on the skin. Photochem Photobiol 84(2):450–462. https://doi.org/10.1111/j.1751-1097.2007.00286.x
De Luca D, Malko AV, Moreno Alonso de Celada R, De Lucas Laguna R, Engle W (2013) Physics and biology of transcutaneous bilirubin assay. In: De Luca D, Engle W, Jackson G (eds) Transcutaneous bilirubinometry. Nova Science Publishers, New York, pp 12–14
Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. Journal of Chiropractic Medicine 15(2):155–163. https://doi.org/10.1016/j.jcm.2016.02.012
McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med (Zagreb) 22(3):276–282
Acknowledgments
We would like to thank Jennifer Bricker-Bolton for proofreading this manuscript and helping with the English language, and Xavier Duran-Jordà for helping with statistical analyses.
Author information
Authors and Affiliations
Contributions
Dr. Silvia Maya-Enero helped design the study, collected data, coordinated and supervised data collection. Helped analyze the results of the study, drafted the initial manuscript, and approved the final manuscript as submitted.
Dr. Júlia Candel-Pau conceptualized and designed the study, designed the data collecting instruments, designed and created the new neonatal color scale, carried out the training of the staff in the use of the new scale, collected data, coordinated and supervised data collection, helped analyze the results of the study, helped draft the initial manuscript, and approved the final manuscript as submitted.
Dr. Jordi Garcia-Garcia helped in the initial study design, helped create the new neonatal color scale and collect data, reviewed and revised the manuscript, and approved the final manuscript as submitted.
Dr. Ana Maria Giménez-Arnau helped conceptualize and design the study, helped create the new neonatal color scale, reviewed and revised the manuscript, and approved the final manuscript as submitted.
Dr. María Ángeles López-Vílchez helped conceptualize and design the study, helped create the new neonatal color scale, collected data, reviewed and revised the manuscript, and approved the final manuscript as submitted.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Communicated by Daniele De Luca
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix. Consent form for parents or legal guardians
Appendix. Consent form for parents or legal guardians
VALIDATION OF A NEONATAL SKIN COLOR SCALE
Justification and objective of the study: Neonatal jaundice affects between 60-85% of term infants and is the most common cause of re-admission to the hospital in the neonatal period. Neonatal Units have protocols for the early detection of pathological jaundice (pathological hyperbilirubinemia). Pathological hyperbilirubinemia poses neonates at risk of developing acute bilirubin encephalopathy and kernicterus (chronic encephalopathy). Detecting pathological hyperbilirubinemia involves measuring total serum bilirubin. The non-invasive determination of transcutaneous bilirubin in neonates has been extensively validated and improved over recent years. It is cheap to use and it decreases the amount of blood samples. However, there still is some concern regarding its reliability depending on gestational age, skin color, and exposure to phototherapy (Grabenhenrich J 2014, Zecca E 2009). This study aims to validate a neonatal skin color scale of our own to later on determine the reliability of transcutaneous bilirubin determination depending on skin color, in order to improve early diagnosis of pathological hyperbilirubinemia and reduce economic costs and neonatal pain by reducing the amount of blood draws.
Implication for patients: This study only entails a non-invasive determination of skin melanin by means of a transcutaneous colorimeter (Mexameter ® MX 18).
Participation is voluntary and the patient can withdraw from the study:
-
1.
Whenever the patient’s parents or legal guardians want,
-
2.
Without having to explain the reasons,
-
3.
With no impact on the newborn’s health care.
Confidentiality: The Service of Pediatrics, Hospital del Mar, guarantees the confidentiality of the patient’s personal and medical data.
Contact: main investigator: Júlia Candel-Pau. Telephone 93 248 35 54 / 93 248 31 11.
(Assistant physician, Neonatology, Hospital del Mar, Barcelona)
Informed consent
Study title: VALIDATION OF A NEONATAL SKIN COLOR SCALE
Rights and permissions
About this article
Cite this article
Maya-Enero, S., Candel-Pau, J., Garcia-Garcia, J. et al. Validation of a neonatal skin color scale. Eur J Pediatr 179, 1403–1411 (2020). https://doi.org/10.1007/s00431-020-03623-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-020-03623-6